why choose us

First received: September 21, 2026

Clinical Trial: Residual Histological Disease Across Treatment Pathways in Chronic Hepatitis B

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Hepatitis B

Study Type: OBSERVATIONAL


Official Title: Residual Histological Disease After Classification by Contemporary Non-Biopsy Treatment Pathways in Treatment-Naïve Chronic Hepatitis B: A Two-Center Retrospective Cohort Study

Brief Summary: This retrospective, two-center observational study evaluates contemporary non-biopsy treatment pathways in treatment-naïve adults with chronic hepatitis B who underwent liver biopsy in routine clinical practice. The study retrospectively reconstructs the evaluable components of the WHO 2024, EASL 2025, APASL 2026, and Turkish Social Security Institution Health Implementation Communiqué (SUT) treatment pathways. The main objectives are to determine the proportion of patients classified as pathway-positive and to…

Read more